Dual radiobiological interpretations of retrospective clinical data: the time factor

References

• AMDUR, R. J., PARSONS," T., FITZGERALD, L. T. and MrtuoN, R. R., 1990, The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapy. International Journal of Radiation Oncology, Biology, Physics, 19, 1377–1381.
   Google Scholar
• ANSCHER, M. S., MONTANA, G. S., DODGE, R., GAYDICA, E. F., DEWITIRST, M. W. and PRosNrrz, L. R., 1993, The lack of impact of treatment time on the outcome of definitive radiotherapy for carcinoma of the prostate. International Journal of Oncology, 3, 707–711.
   PubMed Web of Science ®Google Scholar
• BENTZEN, S. M., 1993, Time—dose relationships for human tumors: estimation from non-randomized studies. In H.-P. Beck-Bornholdt (ed.), Current Topics in Clinical Radiobiology of Tumours. Medical Radiology (Berlin: Springer), pp. 11–26.
   Google Scholar
• BENTZEN, S. M. and THAMES, H. D., 1991, Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiotherapy and Oncology, 22, 161–166.
   PubMed Web of Science ®Google Scholar
• BENTZEN, S. M., THAMES, H. D., OVERGAARD, M., HANSEN, P. V., VON DER MAASE, H. and MEDEA, J., 1989, Clinical radiobiology of malignant melanoma. Radiotherapy and Oncology, 16, 169–182.
   PubMed Web of Science ®Google Scholar
• BEYER, D. C. and BRACHMAN, D. G., 2000, Failure free survival following brachytherapy alone for prostate cancer: com-parison with external beam radiotherapy. Radiotherapy and Oncology, 57, 263–267.
   PubMed Web of Science ®Google Scholar
• BRENNER, D. J. and HALL, E. J., 1999, Fractionation and protraction for radiotherapy of prostate carcinoma. International Journal of Radiation Oncology, Biology, Physics, 43, 1095–1101.
   PubMed Web of Science ®Google Scholar
• D'SOUZA, W. D. and THAMES, H. D., 2001, Is the c/ f3 ratio for prostate cancer low? International Journal of Radiation Oncology, Biology, Physics, 51, 1–3.
   Google Scholar
• DALE, R. G., 1985, The application of the linear—quadratic dose—effect equation to fractionated and protracted radiotherapy. British Journal of Radiology, 58, 515–528.
   PubMed Web of Science ®Google Scholar
• DUBBEN, H. H., 1994, Local control, TCD50, and dose—time prescription habits in radiotherapy of head and neck tumours. Radiotherapy and Oncology, 32, 197–200.
   PubMed Web of Science ®Google Scholar
• DUCHESNE, G. M. and PETERS, L. J., 1999, What is the c/ f3 ratio for prostate cancer? Rationale for hypofractionated high-dose rate brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 44, 747–748.
   PubMed Web of Science ®Google Scholar
• FOWLER, J. F., CHAPPELL, R. and RITTER, M., 2001, Is c/ f3 for prostate really low? International Journal of Radiation Oncology, Biology, Physics, 50, 1021–1031.
   Google Scholar
• FOWLER, J. F. and LINDSTROM, M. J., 1992, Loss of local control with prolongation in radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 23, 457–467.
   PubMed Web of Science ®Google Scholar
• Fu, K. K., PAJAK, T. F., TROTT', A., JONES, C. U., SPENCER, S. A., PHILLIPS, T. L., GARDEN, A. S., RIDGE, J. A., COOPER, J. S. and ANG, K. K., 2000, A radiation therapy oncology group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report to RTOG 9003. International Journal of Radiation Oncology, Biology, Physics, 48, 7–16.
   Google Scholar
• HAUSTERMANS, K. M., HOFLAND, I., VAN POPPEL, H., OYEN, R., AN DE VOORDE, W., BEGG, A. C. and FOWLER, J. F., 1997, Cell kinetic measurements in prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 37, 1067–1070.
   PubMed Web of Science ®Google Scholar
• HoRwrrz, E. M., VICINI, F. A., ZIAJA, E. L., Dmuclloswiu, C. F., STROMBERG, J. S., GUSTAFSON, G. S. and MARTINEZ, A. A., 1997, An analysis of clinical and treatment related prognostic factors on outcome using biochemical control as an end-point in patients with prostate cancer treated with external beam irradiation. Radiotherapy and Oncology, 44, 223–228.
   PubMed Web of Science ®Google Scholar
• KAJANTI, M., HOLSTI, L. R., HOLSTI, P. and MOYKKYNEN, K., 1993, Effect of split-course radiotherapy on survival and local-control in advanced localized prostatic-carcinoma. International Journal of Radiation Oncology, Biology, Physics, 26, 211–216.
   PubMed Web of Science ®Google Scholar
• KING, C. and FOWLER, J. F., 2002, Yes, the cc/fl ratio for prostate cancer is low or 'Methinks the lady doth protest too much about a low cx/fi that is'. International Journal of Radiation Oncology, Biology, Physics, 54, 626–628.
   PubMed Web of Science ®Google Scholar
• KING, C. R. and FOWLER," F., 2001, A simple analytic derivation suggests that prostate cancer cx/fi ratio is low. International Journal of Radiation Oncology, Biology, Physics, 51, 213–214.
   Google Scholar
• KUBAN, D. A., 2002, Presentation. ASTRO 2002 Conference, 12–14 November, 2002, Ottawa.
   Google Scholar
• LAI, P. P., PEREZ, C. A., SHAPIRO, S.J. and LocKETr, M. A., 1990, Carcinoma of the prostate stage B and C: lack of influence of duration of radiotherapy on tumor control and treat-ment supply. International Journal of Radiation Oncology, Biology, Physics, 19, 561–568.
   PubMed Web of Science ®Google Scholar
• LAI, P. P., Pruncll, M. V., KRALL, J. M., ASBELL, S. 0., HANKS, G. E., PEREZ, C. A., RUBIN, P., SAUSE, W. T. and Cox, J. D., 1991, The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the radiation therapy oncology group 75–06 and 77–06 experience. International Journal of Radiation Oncology, Biology, Physics, 21, 925–933.
   Google Scholar
• MACIEJEWSKI, B., WITHERS, H. R., TAYLOR," M. G. and HLINIAK, A., 1989, Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose response and repopulation. International Journal of Radiation Oncology, Biology, Physics, 16, 831–843.
   Google Scholar
• RAGDE, H., ELGAMAL, A. A., SNOW, P. B., BRANDT,", BARTOLUCCI, A. A., NADIR, B. S. and KORB, L. J., 1998, Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45 Gy external beam irradiation in the treatment of patients with clinically localized low to high Gleason grade prostate carcinoma. Cancer, 83, 989–1001.
   Google Scholar
• RAGDE, H., KORB, L. J., ELGAMAL, A. A., GRADO, G. L. and NADIR, B. S., 2000, Modern prostate brachytherapy, prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer, 89, 135–141.
   PubMed Web of Science ®Google Scholar
• SAUSE, W. T., COOPER," S., RUSH, S., AGO, C. T., COSMATOS, D., COUGHLIN, C. T., JAN JAN, N. and LIPSETT, J., 1991, Fraction size in external beam radiation therapy in the treatment of melanoma. International Journal of Radiation Oncology, Biology, Physics, 20, 429–432.
   Google Scholar
• THAMES, H. D., 1985, An 'incomplete-repair' model for survival after fractionated and continuous irradiations. International Journal of Radiation Biology, 47, 319–339.
   Web of Science ®Google Scholar